Nanoparticle-Enhanced Near-Infrared Fluorescence Probes: A Breakthrough in Cancer Imaging Techniques

Recent progress in nanotechnology has dramatically improved the utility of near-infrared fluorescence (NIRF) probes for cancer imaging. This paper examines the benefits of nanoparticles loaded with NIR dyes like indocyanine green (ICG) and DiR, known for their ability to penetrate deep tissues and produce low background autofluorescence. Utilizing the enhanced permeability and retention (EPR) effect, these nanoparticles target tumor tissues efficiently, supporting advanced imaging techniques and precision drug delivery. The review underscores the transformative potential of NIRF imaging in molecular diagnostics, particularly its capability to distinguish malignant tissues at a molecular level. It also explores various NIRF dye types, such as cyanine and BODIPY-based probes, alongside multifunctional agents designed to enhance imaging specificity and therapeutic benefits. Furthermore, the incorporation of targeting mechanisms, including antibodies and small molecules, elevates the accuracy of these probes. Despite challenges like pharmacokinetics and toxicity concerns, the ability of nanoparticle-based probes to enable real-time tumor tracking and multimodal imaging highlights their pivotal role in advancing cancer diagnostics and treatment. By promoting the integration of theranostic approaches, these technologies offer promising avenues for personalized oncology care and improved patient outcomes.